Sergey Brin’s $2 Billion Quest To Tackle Parkinson’s, Bipolar Disorder And Now Autism
The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...
Pharm Exec15h
FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease
Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing ...
Red flags of Parkinson's disease as mum is diagnosed at just 28 years old
Nicole LaBolle initially dismissed her shaking as something fairly common before facing a Parkinson's diagnosis at 28 ...
Samsung recognizes Española Valley High School for innovative Parkinson’s Disease project
Samsung is recognizing Española Valley High School for its student’s efforts to help people dealing with Parkinson’s Disease. Students, in coordination with ...
Mum, 28, thought trembling arm was just 'caffeine shakes' before tragic diagnosis
Nicole LaBolle noticed a tremor in her arm in her '20s but blamed it on drinking too much coffee and a lack of sleep ...
Knowridge11h
A new wearable treatment for Parkinson’s motor fluctuations
The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) injection, the first and only ...
Woman, 28, mistook shaking arm as 'caffeine trembles' before life-altering diagnosis
Nicole LaBolle noticed a tremor in her arm in her '20s but blamed it on drinking too much coffee and a lack of sleep ...
HealthDay on MSN20h
FDA Approves Wearable Infusion Device for Advanced Parkinson Disease
The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...
Cork Beo on MSN20h
Young mum thought shaky arm was 'caffeine trembles' before life-changing diagnosis
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
No-Moat Lundbeck's Strategic Brands Drive Growth but Face Generic Pressure Amid Patent Losses
However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...
Ozzy Osbourne's final show: Black Sabbath to reunite amid frontman's Parkinson's disease
Ozzy Osbourne will come out of touring retirement and reunite with the full Black Sabbath lineup for the first time in 20 ...
The Lancet11h
A new pathway for primary aldosteronism treatment
An oft-repeated message is that primary aldosteronism is not rare; it is quite common. An equally urgent message is that ...